20029-U
ORBO™ Amberlite™ XAD-4チューブ
RC,GFF,F,F (specially cleaned) separators, O.D. × L 13-8 mm × 75 mm , OSHA Versatile Sampler (OVS), pkg of 10 ea
別名:
ORBO™ 65P (OVS) Amberlite™ XAD®-4 specially cleaned, 160/80 mg
material
RC,GFF,F,F (specially cleaned) separators
product line
Amberlite™, ORBO™
composition
Bed A, 160 mg , Bed B, 80 mg
packaging
pkg of 10 ea
manufacturer/tradename
ORBO™ 65P
technique(s)
active air sampling: suitable
O.D. × L
13-8 mm × 75 mm , OSHA Versatile Sampler (OVS)
matrix
XAD-4 (specially cleaned)
application(s)
air monitoring
environmental
industrial hygiene
compatibility
for sampling Polar and non-polar VOCs; select aldehydes
Quality Level
関連するカテゴリー
General description
ORBO™ 65P OSHA Versatile Sampler (OVS) is used for sampling both polar and non-polar volatile organic compounds (VOCs). It is particularly suitable for selecting aldehydes. The product is capped at the inlet and outlet to minimize environmental exposure.
It is commonly used as an adsorbent to collect and retain the volatile organic compound in the air samples, allowing for accurate determination of air concentrations.
It is commonly used as an adsorbent to collect and retain the volatile organic compound in the air samples, allowing for accurate determination of air concentrations.
Legal Information
Amberlite is a trademark of DuPont de Nemours, Inc.
ORBO is a trademark of Sigma-Aldrich Co. LLC
XAD is a registered trademark of The Dow Chemical Company or an affiliated company of Dow
保管分類
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
20029-U:
jan
Perfluorooctanesulfonate (PFOS) Conversion from N-Ethyl-N-(2-hydroxyethyl)-perfluorooctanesulfonamide (EtFOSE) in male Sprague Dawley rats after inhalation exposure.
Sue C, et al.
Environmental Research, 155, 307-313 (2017)
Anne Ørbo et al.
The Journal of steroid biochemistry and molecular biology, 113(1-2), 139-149 (2009-01-14)
Patients with endometrial hyperplasia representing preliminary stages of endometrial cancer have shown to respond to therapy in 100% of the cases when treated with levonorgestrel-impregnated intrauterine device. Anti-proliferative effect has also been reported after application of an anti-progestin impregnated intrauterine
H Stalsberg et al.
Virchows Archiv. A, Pathological anatomy and histopathology, 414(5), 415-422 (1989-01-01)
The autopsies of 12 victims from two snow avalanches in North-Norway are reported. Supportive evidence from non-autopsied and surviving victims is included. Consistent autopsy findings were prominent lung oedema, moderate cerebral oedema, extreme contraction of the left ventricle, petechiae in
Anne Beate Vereide et al.
Gynecologic oncology, 97(3), 740-750 (2005-05-12)
The aim of the study was to investigate apoptosis as a growth regulatory mechanism of gestagen in endometrial precancers and to compare differences in the apoptotic cascade after high and low dose gestagen regimens. Pre- and post-treatment paraffin-embedded endometrial hyperplasia
A Ørbo et al.
BJOG : an international journal of obstetrics and gynaecology, 123(9), 1512-1519 (2015-12-03)
To investigate relapse rates after the successful treatment of patients with non-atypical endometrial hyperplasia who were randomised to either a levonorgestrel-impregnated intrauterine system (LNG-IUS; Mirena(®) ) or two regimens of oral medroxyprogesterone acetate (MPA) after primary histological response. A multicentre
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）